Evidence map›Paper›PMID 32333768›Full record

ArticleThe Journal of infectious diseases2020

The Stringent Response Contributes to Persistent Methicillin-Resistant Staphylococcus aureus Endovascular Infection Through the Purine Biosynthetic Pathway.

Liang Li, Arnold S Bayer, Ambrose Cheung, Lou Lu, Wessam Abdelhady, Niles P Donegan, Jong-In Hong, Michael R Yeaman, Yan Q Xiong

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.5field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Antimicrobial Efficacy against Antibiotic-TolerantAntibiotics (Basel, Switzerland) · 2022
    Article
  11. Identification of Methicillin-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Liang LiLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.
Arnold S BayerLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.
Ambrose CheungGeisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
Lou LuLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.
Wessam AbdelhadyLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.
Niles P DoneganGeisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
Jong-In HongDepartment of Chemistry, Seoul National University, Seoul, Korea.
Michael R YeamanLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.
Yan Q XiongLundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.
Harbor–UCLA Medical Center · USUCLA Medical Center · USDartmouth College · USSeoul National University · KR

Funding

Systems Epigenomics of Persistent Bloodstream InfectionU19AI172713 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI ELAINE F REED · 2023 to 2026
$11.6M
Systems Immunolobiology of Antibiotic-Persistent MRSA InfectionU01AI124319 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI YEAMAN, MICHAEL R · 2016 to 2020
$10.1M
Mechanisms and Circumvention of Daptomycin Resistance in Streptococcus mitisR01AI130056 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI BAYER, ARNOLD S · 2018 to 2022
$2.4M
The role of purine biosynthesis and stringent response in persistent MRSA endovascular infectionsR01AI139244 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI XIONG, YAN Q. · 2019 to 2023
$2.2M
Mitigating Resistance & Virulence in MRSAR33AI111661 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI YEAMAN, MICHAEL R · 2016 to 2018
$1.2M
NIAID NIH HHS R01 AI130056NIAID NIH HHS R01 AI139244NIAID NIH HHS R33 AI111661NIAID NIH HHS U01 AI124319NIAID NIH HHS U19 AI172713
6 · The paper itself

Abstract

Persistent methicillin-resistant Staphylococcus aureus (MRSA) endovascular infections represent a significant clinical-therapeutic challenge. Of particular concern is antibiotic treatment failure in infections caused by MRSA that are "susceptible" to antibiotic in vitro. In the current study, we investigate specific purine biosynthetic pathways and stringent response mechanism(s) related to this life-threatening syndrome using genetic matched persistent and resolving MRSA clinical bacteremia isolates (PB and RB, respectively), and isogenic MRSA strain sets. We demonstrate that PB isolates (vs RB isolates) have significantly higher (p)ppGpp production, phenol-soluble-modulin expression, polymorphonuclear leukocyte lysis and survival, fibronectin/endothelial cell (EC) adherence, and EC damage. Importantly, an isogenic strain set, including JE2 parental, relP-mutant and relP-complemented strains, translated the above findings into significant outcome differences in an experimental endocarditis model. These observations indicate a significant regulation of purine biosynthesis on stringent response, and suggest the existence of a previously unknown adaptive genetic mechanism in persistent MRSA infection.

Indexed as

AnimalsAnti-Bacterial AgentsBacteremiaBiosynthetic PathwaysDisease Models, AnimalEndocarditisHumansMethicillinMethicillin-Resistant Staphylococcus aureusPurinesRabbitsStaphylococcal InfectionsAnti-Bacterial AgentsMethicillinPurinesendovascular infectionMRSApersistence(p)ppGpppurine biosynthesisstringent response

Identifiers

PMID32333768
PMCPMC7459137
OpenAlexW3017545838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.